Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis

Experimental Neurology

Volumn 191, Issue 2, 2005, Pages 331-336

  Kiaei, Mahmoud ^a   Kipiani, Khatuna ^a   Chen, Junyu ^a   Calingasan, Noel Y ^a   Beal, M Flint ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Inflammation; Peroxisome proliferator activated receptor gamma

Indexed keywords

3 NITROTYROSINE; CD40 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLIOSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOTONEURON; MOTOR PERFORMANCE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SURVIVAL TIME; TRANSGENIC MOUSE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLIOSIS; LUMBOSACRAL REGION; MICE; MICE, TRANSGENIC; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PPAR GAMMA; PSYCHOMOTOR PERFORMANCE; SPINAL CORD; SUPEROXIDE DISMUTASE; SURVIVAL RATE; THIAZOLIDINEDIONES; TYROSINE; WEIGHT LOSS;

EID: 11844269951     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.10.007     Document Type: Article

References (33)

1. G. Almer, S. Vukosavic, N. Romero, and S. Przedborski Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis J. Neurochem. 72 1999 2415 2425
2. T. Breidert, J. Callebert, M.T. Heneka, G. Landreth, J.M. Launay, and E.C. Hirsch Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's Disease J. Neurochem. 82 2002 615 624
3. A. Chawla, E.J. Schwarz, D.D. Dimaculangan, and M.A. Lazar Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation Endocrinology 135 1994 798 800
4. P.R. Colville-Nash, S.S. Qureshi, D. Willis, and D.A. Willoughby Inhibition of inducible nitric oxide synthase by peroxisome proliferator- activated receptor agonists: correlation with induction of heme oxygenase 1 J. Immunol. 161 1998 978 984
5. T. Dehmer, M.T. Heneka, M. Sastre, J. Dichgans, and J.B. Schulz Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with Iκbα induction and block of NFκB and iNOS activation J. Neurochem. 88 2004 494 501
6. J.L. Elliott Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis Brain Res. Mol. Brain Res. 95 2001 172 178
7. D.L. Feinstein, E. Galea, V. Gavrilyuk, C.F. Brosnan, C.C. Whitacre, L. Dumitrescu-Ozimek, G.E. Landreth, H.A. Pershadsingh, G. Weinberg, and M.T. Heneka Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis Ann. Neurol. 51 2002 694 702
8. R.M. Friedlander, R.H. Brown, V. Gagliardini, J. Wang, and J. Yuan Inhibition of ICE slows ALS in mice Nature 392 1998 560
9. P. Ghezzi, R. Bernardini, R. Giuffrida, M. Bellomo, C. Manzoni, D. Comoletti, E. Di Santo, F. Beningi, and T. Mennini Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration Eur. Cytokine Network 9 1998 139 144
10. D.W. Gilroy, P.R. Colville-Nash, D. Willis, J. Chivers, M.J. Paul-Clark, and D.A. Willoughby Inducible cyclooxygenase may have anti-inflammatory properties Nat. Med. 5 1999 698 701
11. M.E. Gurney Transgenic-mouse model of amyotrophic lateral sclerosis N. Engl. J. Med. 331 1994 1721 1722
12. E.D. Hall, J.A. Oostveen, and M.E. Gurney Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS Glia 23 1998 249 256
13. M.T. Heneka, D.L. Feinstein, E. Galea, M. Gleichmann, U. Wullner, and T. Klockgether Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine induced apoptotic cell death by inhibition of inducible nitric oxide synthase J. Neuroimmunol. 100 1999 156 168
14. M.T. Heneka, T. Klockgether, and D.L. Feinstein Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase and cell death in vivo J. Neurosci. 20 2000 6862 6867
15. K. Hensley, R.A. Floyd, B. Gordon, S. Mou, Q.N. Pye, C. Stewart, M. West, and K. Williamson Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93-SOD1 mouse model of amyotrophic lateral sclerosis J. Neurochem. 82 2002 365 374
16. A. Hirano Neuropathology of ALS: an overview Neurology 47 1996 S63 S66
17. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
18. T. Kielian, and P.D. Drew Effects of peroxisome proliferator-activated receptor-γ agonists on central nervous system inflammation J. Neurosci. Res. 71 2003 315 325
19. M. Li, V.O. Ona, C. Guegan, M. Chen, V. Jackson-Lewis, L.J. Andrews, A.J. Olszweski, P.E. Stieg, J.P. Lee, S. Przedborski, and R.M. Friedlander Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model Science 288 2000 335 339
20. Y. Maeshiba, Y. Kiyota, K. Yamashita, Y. Yoshimura, M. Motohashi, and S. Tanayma Disposition of the new antidiabetic agent pioglitazone in rats, dogs and monkeys Arzneimittel-forschung 47 1997 29 35
21. E. Mueller, P. Sarraf, P. Tontonoz, R.M. Evans, K.J. Martin, M. Zhang, C. Fletcher, S. Singer, and B.M. Spiegelman Terminal differentiation of human breast cancer through PPAR gamma Mol. Cell. 1 1998 465 470
22. M.D. Nguyen, J.P. Julien, and S. Rivest Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration Ann. Neurol. 50 2001 630 639
23. M.K. Olsen, S.L. Roberds, B.R. Ellerbrock, T.J. Fleck, D.K. McKinley, and M.E. Gurney Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord Ann. Neurol. 50 2001 730 740
24. H.A. Pershadsingh, M.T. Heneka, R. Saini, N.M. Amin, D.J. Broeske, and D.L. Feinstein Effect of pioglitazone treatment in a patient with secondary multiple sclerosis J. Neuroinflammation 20 1 (1) 2004 3
25. T.V. Petrova, K.T. Akama, and L.J. Van Eldik Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric oxide synthase by 15-deoxy-Delta 12, 14-prostaglandin J2 Proc. Natl. Acad. Sci. U. S. A. 96 1999 4668 4673
26. M. Ricote, A.C. Li, T.M. Wilson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
27. D.R. Rosen, T. Siddique, and D. Patterson Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62
28. D. Schiffer, S. Cordera, P. Cavalla, and A. Migheli Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis J. Neurol. Sci. 139 Suppl. 1996 27 33
29. P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer Genes Dev. 8 1994 1224 1234
30. M.J. West, L. Slomianka, and H.J. Gundersen Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator Anat. Rec. 231 1991 482 497
31. P.C. Wong, C.A. Pardo, D.R. Borchelt, M.K. Lee, N.G. Copeland, N.A. Jenkins, S.S. Sisodia, D.W. Cleveland, and D.L. Price An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria Neuron 14 1995 1105 1116
32. T. Yoshihara, S. Ishigaki, M. Yamamoto, Y. Liang, J. Niwa, H. Takeuchi, M. Doyu, and G. Sobue Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis J. Neurochem. 80 2002 158 167
33. J. Youssef, and M. Badr Role of peroxisome proliferator-activated receptors in inflammation control J. Biomed. Biotechnol. 3 2004 156 166